Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.

Japanese studies have defined the discrete 2209-2248 amino acid region of the non-structural 5A protein (NS5A(2209-2248)) of hepatitis C virus genotype 1b (HCV 1b) isolates as the interferon sensitivity determining region (ISDR). European studies did not confirm these results since most of the ISDR sequences harboured an intermediate profile. Recently, a direct interaction between the NS5A protein, involving the ISDR, and the interferon-induced protein kinase (PKR) has been reported and presented as a possible explanation of HCV interferon resistance. In the present study, the entire NS5A amino acid sequence from 11 resistant and eight sensitive strains from European HCV 1b isolates was inferred from direct sequencing. The previously described important amino acid stretches and positions in NS5A were compared between the resistant and sensitive groups. Although some variations were observed, no clear differences could be directly correlated with the interferon sensitivity. However, sensitive strains were different, owing to more amino acid changes when compared to a consensus sequence from all strains. The carboxy-terminal region and especially the previously reported NS5A/V3 region showed most of the variations. Moreover, the conformational analysis of NS5A by secondary structure prediction allowed the differentiation of most sensitive strains from resistant ones. It was concluded that other regions different from ISDR were involved in resistance to interferon maybe via the interaction between NS5A and PKR.

[1]  P. Y. Chou,et al.  Prediction of the secondary structure of proteins from their amino acid sequence. , 2006 .

[2]  Y. Shiratori,et al.  Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. , 1997, Journal of virology.

[3]  C. Rice,et al.  Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase , 1997, Journal of virology.

[4]  S. Polyak,et al.  Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b , 1997, Journal of medical virology.

[5]  C. Bréchot,et al.  Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. , 1997, Gastroenterology.

[6]  Y. Sasaguri,et al.  The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast. , 1997, Biochemical and biophysical research communications.

[7]  P. Simmonds,et al.  The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. , 1997, Biochemical and biophysical research communications.

[8]  L. Stuyver,et al.  Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. , 1997, Journal of hepatology.

[9]  P. Simmonds,et al.  Virus 'quasispecies': making a mountain out of a molehill? , 1997, The Journal of general virology.

[10]  G. Duverlie,et al.  Direct blotting electrophoresis for sequencing and genotyping hepatitis C virus. , 1997, Journal of virological methods.

[11]  M. Katze,et al.  Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. , 1997, Virology.

[12]  J. Hoofnagle,et al.  The interferon sensitivity determining region: All hepatitis C virus isolates are not the same , 1997, Hepatology.

[13]  K. Chayama,et al.  Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity–determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection , 1997, Hepatology.

[14]  S. Zeuzem,et al.  Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa , 1997, Hepatology.

[15]  N. Enomoto,et al.  Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon‐β therapy , 1997, Hepatology.

[16]  J. Hoofnagle,et al.  THE TREATMENT OF CHRONIC VIRAL HEPATITIS , 1997 .

[17]  K. Shimotohno,et al.  The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation , 1997, Journal of virology.

[18]  N Enomoto,et al.  Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. , 1996, The New England journal of medicine.

[19]  P. Marcellin,et al.  Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C , 1995, Hepatology.

[20]  N. Enomoto,et al.  Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. , 1995, The Journal of clinical investigation.

[21]  K. Shimotohno,et al.  Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A , 1995, Journal of virology.

[22]  C Geourjon,et al.  ANTHEPROT 2.0: a three-dimensional module fully coupled with protein sequence analysis methods. , 1995, Journal of molecular graphics.

[23]  M. Tong,et al.  Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.

[24]  K. Shimotohno,et al.  Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. , 1994, Biochemical and biophysical research communications.

[25]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[26]  H. Hochkeppel,et al.  Strong transient expression of the type I interferon–induced MxA protein in hepatitis A but not in acute hepatitis B and C , 1994, Hepatology.

[27]  Amos Bairoch,et al.  The PROSITE dictionary of sites and patterns in proteins, its current status , 1993, Nucleic Acids Res..

[28]  C. Rice,et al.  Expression and identification of hepatitis C virus polyprotein cleavage products , 1993, Journal of virology.

[29]  S. Zebedee,et al.  Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  N. Kato,et al.  Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G Deléage,et al.  An algorithm for protein secondary structure prediction based on class prediction. , 1987, Protein engineering.

[32]  M. Fitzgibbon,et al.  Purification and characterization of the NS3 serine protease domain of hepatitis C virus expressed in Saccharomyces cerevisiae. , 1997, The Journal of general virology.

[33]  A. Zuckerman,et al.  The molecular medicine of viral hepatitis , 1997 .

[34]  K Nishikawa,et al.  The folding type of a protein is relevant to the amino acid composition. , 1986, Journal of biochemistry.